NL-OMON40647撤回不适用
Artificial Pancreas Research at the Intensive Care: AMC OLVG Trial - APRICOT
Onze Lieve Vrouwe Gasthuis0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age >= 18 years
- •Diabetic and non-diabetic patients with an anticipated stay of at least 24 hours of admission to the intensive care
- •Indication for glucose regulation with insulin (according to the current glucose treatment protocol)
- •Patient or surrogate understands and signs informed consent document.
排除标准
- •Patients with diabetic ketoacidosis or hyperosmolar hyperglycaemic non-ketotic coma
- •Patients who are receiving therapeutic hypothermia
- •Pregnancy
- •Any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient
研究者
相似试验
已完成
不适用
Is the Artificial Pancreas, Without Carbohydrate Counting, Efficient and Safe in an Outpatient SettingAutoimmune DiabetesType 1 DiabetesNCT04793165Hospital Italiano de Buenos Aires5
已完成
不适用
Assessment of Hybrid Use of an Artificial Pancreas in a Home setting for Two Months in Patients with Type 1 Diabetes - DiAs Hybrid Home TrialdiabetesNL-OMON41525Academisch Medisch Centrum12
已完成
不适用
DiaPort Closed-Loop Artificial PancreasType 1 Diabetes MellitusNCT01555788University Hospital, Montpellier10
进行中（未招募）
不适用
Closed Loop From Onset in Type 1 DiabetesDiabetes MellitusType 1 DiabetesNCT02871089University of Cambridge96
尚未招募
不适用
Efficacy and Safety of an Artificial-pancreas-like Learning-based Control in Type 1 Diabetes on Multiple Daily Injection TherapyDiabetes Mellitus, Type 1NCT06418464Peking University People's Hospital120